Sutro Biopharma (STRO) EBITDA Margin Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) EBITDA Margin Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -13,584.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13,584.00 |
| Sep 30, 2025 | 29,723.00 |
| Jun 30, 2025 | 18,414.00 |
| Mar 31, 2025 | 4,127.00 |
| Dec 31, 2024 | -47,861.00 |
| Sep 30, 2024 | -53,710.00 |
| Jun 30, 2024 | 25,413.00 |
| Mar 31, 2024 | -10,179.00 |
| Dec 31, 2023 | 60,817.00 |
| Sep 30, 2023 | -17,572.00 |
| Jun 30, 2023 | -37,454.00 |
| Mar 31, 2023 | 33,033.00 |
| Dec 31, 2022 | -24,137.00 |
| Sep 30, 2022 | 32,277.00 |
| Jun 30, 2022 | -3,402.00 |
| Mar 31, 2022 | -53,393.00 |
| Dec 31, 2021 | -2,874.00 |
| Sep 30, 2021 | -34,755.00 |
| Jun 30, 2021 | 13,842.00 |
| Mar 31, 2021 | 13,851.00 |